News

Published on 14 Sep 2023 on GuruFocus.com via Yahoo Finance

Insider Buying: John Finley Acquires 15,000 Shares of Palisade Bio Inc

Article preview image

On September 13, 2023, John Finley, CEO, CFO, and Director of Palisade Bio Inc (NASDAQ:PALI), made a significant insider purchase of 15,000 shares of the company's stock. This move is noteworthy and deserves a closer look.

Who is John Finley?

Warning! GuruFocus has detected 1 Warning Sign with PALI. Click here to check it out. PALI 30-Year Financial DataThe intrinsic value of PALI

Read the rest of the article
NASDAQ.PALI price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Insider Buying: John Finley Acquires 15,000 Shares of Palisade Bio Inc

On September 13, 2023, John Finley, CEO, CFO, and Director of Palisade Bio Inc (NASDAQ:PALI), mad...

GuruFocus.com via Yahoo Finance 14 Sep 2023
Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session By...

Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Investing.com 7 Sep 2023
Palisade (PALI) In-Licenses Rights for IBD Candidate, Stock Up

Palisade Bio PALI announced that it is in-licensing exclusive worldwide rights from private biote...

Zacks via Yahoo Finance 7 Sep 2023
Palisade Bio’s stock more than doubles on news of licensing deal with Giiant Pharma for IBD...

Palisade Bio Inc.’s stock more than doubled in price on Wednesday, after the company announced a ...

Market Watch 6 Sep 2023
Palisade Bio, Inc. (PALI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

A downtrend has been apparent in Palisade Bio, Inc. (PALI) lately. While the stock has lost 7.6% ...

Zacks via Yahoo Finance 23 May 2023
Palisade Bio, Inc. (PALI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

The price trend for Palisade Bio, Inc. (PALI) has been bearish lately and the stock has lost 8.7%...

Zacks via Yahoo Finance 17 Apr 2023
Palisade (PALI) Enrolls First Patient in LB1148 Study in China

Palisade PALI, a biopharmaceutical company advancing therapies for acute and chronic gastrointest...

Zacks via Yahoo Finance 6 Apr 2023
Why Heska Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session...

Why Heska Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Sess...

Investing.com 3 Apr 2023
What Makes Palisade Bio, Inc. (PALI) a New Buy Stock

Palisade Bio, Inc. (PALI) could be a solid choice for investors given its recent upgrade to a Zac...

Zacks via Yahoo Finance 29 Mar 2023
Wall Street-Heavily Traded

Here are the ten most active Big Board issues at this time

WJFW Rhinelander 30 Dec 2022

Copyright Statfolio @ 2025

Social Accounts